arrow
Back
M

Matko Kalac

pfizer inc.

13H-index
120Paper Count
778Citation Count
Published Papers 13
Publication Date
ARCHES 5-year Survival with Enzalutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients
err2026-02-03
err0
errOAAI
errAndrew J. Armstrong; Daniel P. Petrylak; Neal D. Shore; Russell Z. Szmulewitz; Jeffrey Holzbeierlein; Arnauld Villers; Antonio Alcaraz; Boris Alekseev; Taro Iguchi; Francisco Gomez-Veiga; Ruslan Croitoru; Ruishan Wu; Matko Kalac; Yiyun Tang; Arnulf Stenzl; Arun A. Azad
errShare
errSave
Enzalutamide with or without leuprolide in patients with high-risk biochemically recurrent prostate cancer: EMBARK post hoc analysis by age
err2025-11-15
err0
PREAI
errNeal D. Shore; Ugo De Giorgi; Matko Kalac; Yiyun Tang; Ruslan Croitoru; Matt Rosales; Melissa J. Huynh; Igle J. de Jong; Christopher P. Evans; Flavio M. Carcano; Stephen J. Freedland
errShare
errSave
Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer
err2025-10-01
err1
PREAI
errShore, Neal D.; Luz, Murilo de Almeida; De Giorgi, Ugo; Gleave, Martin; Gotto, Geoffrey T.; Pieczonka, Christopher M.; Haas, Gabriel P.; Kim, Choung-Soo; Ramirez-Backhaus, Miguel; Rannikko, Antti; Kalac, Matko; Sridharan, Swetha; Rosales, Matt; Tang, Yiyun; Tutrone Jr, Ronald F.; Venugopal, Balaji; Villers, Arnauld; Woo, Henry H.; Wang, Fong; Freedland, Stephen J.
errShare
errSave
Talazoparib plus enzalutamide in men with metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial
err2025-07-16
err0
PREAI
errNeeraj Agarwal; Arun A Azad; Joan Carles; André P Fay; Nobuaki Matsubara; Cezary Szczylik; Ugo De Giorgi; Jae Young Joung; Peter C C Fong; Eric Voog; Robert J Jones; Neal D Shore; Fred Saad; Curtis Dunshee; Stefanie Zschäbitz; Jan Oldenburg; Xun Lin; Cynthia G Healy; Matko Kalac; Dana Kennedy; Karim Fizazi
errShare
errSave
Talazoparib plus enzalutamide in men with HRR-deficient metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial
err2025-07-16
err0
PREAI
errKarim Fizazi; Arun A Azad; Nobuaki Matsubara; Joan Carles; André P Fay; Ugo De Giorgi; Jae Young Joung; Peter C C Fong; Eric Voog; Robert J Jones; Neal D Shore; Curtis Dunshee; Stefanie Zschäbitz; Jan Oldenburg; Dingwei Ye; Xun Lin; Matko Kalac; A Douglas Laird; Dana Kennedy; Neeraj Agarwal
errShare
errSave
Efficacy of talazoparib and enzalutamide in mCRPC patients previously treated with androgen receptor pathway inhibitors (ARPI) or docetaxel: Post hoc analysis from both cohorts in TALAPRO-2 study
err2024-09-01
err1
PREAI
errAgarwal, N.; Azad, A. A.; Galceran, J. C.; Fay, A. P.; Matsubara, N.; Szczylik, C.; De Giorgi, U.; Joung, J. Y.; Fong, P. C.; Voog, E.; Jones, R. J.; Shore, N. D.; Dunshee, C.; Zschaebitz, S.; Oldenburg, J.; Lin, X.; Laird, D.; Kalac, M.; Kennedy, D.; Fizazi, K.
errShare
errSave
Enzalutamide (enza) with or without leuprolide in patients (pts) with high-risk biochemically recurrent (hrBCR) prostate cancer (PC): EMBARK post hoc analysis by age
err2024-09-01
err0
PREAI
errShore, N. D.; De Giorgi, U.; Gleave, M. E.; Kalac, M.; Tang, Y.; Croitoru, R.; Rosales, M.; Huynh, M.; Tammela, T.; de Jong, I. Jan; Evans, C.; Carcano, F. M.; Freedland, S. J.
errShare
errSave
Incidence of hematologic toxicities in the homologous recombination repair (HRR)-deficient population of the TALAPRO-2 trial and their potential association with germline vs somatic origin of HRR gene alterations
err2024-09-01
err0
PREAI
errAzad, A. A.; Agarwal, N.; Shore, N. D.; Galceran, J. C.; Fay, A. P.; Matsubara, N.; Saad, F.; De Giorgi, U.; Joung, J. Y.; Fong, P. C.; Zschaebitz, S.; Piulats Rodriguez, J. M.; Yip, S. M.; Liu, G.; DeAnnuntis, L.; Lin, X.; Laird, D.; Kalac, M.; Fizazi, K.
errShare
errSave
Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL)
err2020-02-05
err28
errOAAI
errXu, Xin; Kalac, Matko; Markson, Michael; Chan, Mark; Brody, Joshua D.; Bhagat, Govind; Ang, Rosalind L.; Legarda, Diana; Justus, Scott J.; Liu, Feng; Li, Qingshan; Xiong, Huabao; Ting, Adrian T.
errShare
errSave
Development and Characterization of a Novel CD19CherryLuciferase (CD19CL) Transgenic Mouse for the Preclinical Study of B-Cell Lymphomas
err2012-07-15
err11
errOAAI
errScotto, Luigi; Kruithof-de Julio, Marianna; Paoluzzi, Luca; Kalac, Matko; Marchi, Enrica; Buitrago, Jairo Baquero; Amengual, Jennifer; Shen, Michael M.; O'Connor, Owen A.
errShare
errSave
Dual targeting of epigenetic pathways and NF-kappaB in diffuse large B-cell lymphoma
err2012-04-01
err0
PREAI
errDeng, Changchun; Kalac, Matko; Amengual, Jennifer; Marchil, Enrica; Scotto, Luigi; O'Connor, Owen A.
errShare
errSave
A critical appraisal of conventional and investigational drug therapy in patients with hypereosinophilic syndrome and clonal eosinophilia
errCANCER
IF5.1
err2007-08-20
err30
PREAI
errKalac, Matko; Quintas-Cardama, Alfonso; Vrhovac, Radovan; Kantarjian, Hagop; Verstovsek, Srdan
errShare
errSave